Abstract
Background: Nanocarriers have been a part of drug delivery for some decades now. Due to the enormous advantages offered by them, they are replacing the conventionally available systems.
Objective: The objective of the current review is to focus wider applications of these nanocarriers in drug delivery, diagnosis, imaging, and targeting as well. It also focuses on the different types of nanocarriers, method of preparation, characterization and most advanced uses or application in medicine.
Methods: Literature has been reviewed intensely. Data from various sources like NCBI PubMed and other valued journals have been reviewed thoroughly. Various research investigations related to nanocarriers systems have been compiled.
Results: Selection of the nanocarriers type as well as their composition depends upon the disease and the application for which it is to be used. Nanocarriers have been investigated for various diseases such as cancer drug delivery, cardiovascular drug delivery, insulin delivery, antimalarial drug delivery, central nervous system drug delivery, ophthalmic, pulmonary and brain delivery, etc.
Conclusion: Nanotherapy has led to the advancement in the delivery of chemotherapeutic drugs in cancer because of their characteristic enhanced permeation and retention in the tumor tissue. Also, its applications in various other aspects of therapeutics have been extraordinary and much more is yet to be explored.
Keywords: Nanotechnology, nanocarriers, nanotherapy, cancer drug delivery, cardiovascular, chemotherapeutic.
Graphical Abstract
Current Nanomedicine
Title:Nanocarriers For Drug Delivery: Mini Review
Volume: 8 Issue: 2
Author(s): Vishal Girdhar, Shalini Patil, Saswata Banerjee and Gautam Singhvi*
Affiliation:
- Department of Pharmacy, Industrial Research Laboratory, Birla Institute of Technology and Science, Pilani, Rajasthan,India
Keywords: Nanotechnology, nanocarriers, nanotherapy, cancer drug delivery, cardiovascular, chemotherapeutic.
Abstract: Background: Nanocarriers have been a part of drug delivery for some decades now. Due to the enormous advantages offered by them, they are replacing the conventionally available systems.
Objective: The objective of the current review is to focus wider applications of these nanocarriers in drug delivery, diagnosis, imaging, and targeting as well. It also focuses on the different types of nanocarriers, method of preparation, characterization and most advanced uses or application in medicine.
Methods: Literature has been reviewed intensely. Data from various sources like NCBI PubMed and other valued journals have been reviewed thoroughly. Various research investigations related to nanocarriers systems have been compiled.
Results: Selection of the nanocarriers type as well as their composition depends upon the disease and the application for which it is to be used. Nanocarriers have been investigated for various diseases such as cancer drug delivery, cardiovascular drug delivery, insulin delivery, antimalarial drug delivery, central nervous system drug delivery, ophthalmic, pulmonary and brain delivery, etc.
Conclusion: Nanotherapy has led to the advancement in the delivery of chemotherapeutic drugs in cancer because of their characteristic enhanced permeation and retention in the tumor tissue. Also, its applications in various other aspects of therapeutics have been extraordinary and much more is yet to be explored.
Export Options
About this article
Cite this article as:
Girdhar Vishal , Patil Shalini , Banerjee Saswata and Singhvi Gautam *, Nanocarriers For Drug Delivery: Mini Review, Current Nanomedicine 2018; 8 (2) . https://dx.doi.org/10.2174/2468187308666180501092519
DOI https://dx.doi.org/10.2174/2468187308666180501092519 |
Print ISSN 2468-1873 |
Publisher Name Bentham Science Publisher |
Online ISSN 2468-1881 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacophore Modeling, Atom Based 3D-QSAR and Docking Studies of Protein Tyrosine Phosphatase 1B Inhibitors
Letters in Drug Design & Discovery The Neurotrophins and Their Role in Alzheimers Disease
Current Neuropharmacology Effect of Aglycon and Glycoside Flavonoid-Enriched Extracts Obtained from Buxus sempervirens L. on Glucose and Lipid Metabolism in Diabetic Rats
Cardiovascular & Hematological Agents in Medicinal Chemistry Stromal Cell-Derived Factor (SDF) 2 and the Endoplasmic Reticulum Stress Response of Trophoblast Cells in Gestational Diabetes Mellitus and <i>In vitro</i> Hyperglycaemic Condition
Current Vascular Pharmacology Bioactive Compound and Nanotechnology: A Novel Delivery Perspective for Diabetic Retinopathy
Current Bioactive Compounds Calpains as a Target for Therapy of Neurodegenerative Diseases: Putative Role of Lithium
Current Drug Metabolism Hormone-Integrin Cross Talk and Angiogenesis Modulation
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Editorial [Hot Topic: GPR30/GPER vs. ERalpha and ERbeta: Why Estrogens Need so Many Receptors (Guest Editor: Marcello Maggiolini)]
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Beta-Blockers as First Line Treatment of Hypertension: A Proponents View
Current Hypertension Reviews 25 Hydroxyvitamin D Levels are Negatively and Independently Associated with Fat Mass in a Cohort of Healthy Overweight and Obese Subjects
Endocrine, Metabolic & Immune Disorders - Drug Targets Brachial-Ankle Pulse Wave Velocity in the Measurement of Arterial Stiffness: Recent Evidence and Clinical Applications
Current Hypertension Reviews Mesenchymal Stem Cell Therapy in Intracerebral Haemorrhagic Stroke
Current Medicinal Chemistry Expression and Regulation of Excitation-Contraction Coupling Proteins in Aging Skeletal Muscle
Current Aging Science Sweet and Sour - Oxidative and Carbonyl Stress in Neurological Disorders
CNS & Neurological Disorders - Drug Targets Targeting Chemokine (C-X-C motif) Receptor 3 in Thyroid Autoimmunity
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Gadolinium-Contrast Toxicity in Patients with Kidney Disease: Nephrotoxicity and Nephrogenic Systemic Fibrosis
Current Drug Safety Effects of Olive Oil on TNF-α and IL-6 in Humans: Implication in Obesity and Frailty
Endocrine, Metabolic & Immune Disorders - Drug Targets Plasma Glucose Lowering Activity of Palmatine and its Effect on Liver, Kidney and Antioxidant Enzymes Parameters in STZ Induced Diabetic Rat Model
Current Bioactive Compounds In Vitro Unfolding of Insulin: Characterization of Intermediates and Putative Unfolding Pathway
Protein & Peptide Letters Meet Our Editorial Board Member:
Current Diabetes Reviews